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Abstract
Background: Prehypertension (pre-HTN), similar to hypertension, has been associated with an elevated risk of
cardiovascular disease. The aim of this study was to determine whether the Sasang constitution (SC) types could
also be independent risk factors for pre-HTN.
Methods: A total of 2,806 eligible subjects, older than 20 years old from 25 medical clinics, participated. Clinical
data, including the blood pressure, age, height, weight, and data from blood tests, were collected. One-way ANOVA
with Scheffé’s post-hoc analysis and the chi-square test were used, according to the SC and sex. Logistic regression
was used to generate the odds ratios (ORs) and 95 % confidence interval (CI) for pre-HTN.
Results: The pre-HTN prevalence rates of the Soeumin type, Soyangin type and Tae-eumin type were 59.4 %, 60.1 %
and 74.9 %, respectively, in men (p < 0.001) and 41.7 %, 44.4 % and 58.3 % in women (p < 0.001). The Soyangin type
was not more associated with increased ORs than the Soeumin type in any of the subjects with pre-HTN. Even after
adjusting for sex, BMI, FBG, TC, TGs, HDL, and LDL, the Tae-eumin type in men was associated with increased ORs of
pre-HTN compared with the Soeumin type (OR 1.57, 95 % CI 1.03–2.39), but the Tae-eumin type in women was not
associated with pre-HTN.
Conclusions: This study suggested that the Tae-eumin type combined with sex might be significantly and
independently associated with pre-HTN, especially high pre-HTN.
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Background
Hypertension (HTN) is one of main risk factors for car-
diovascular diseases, such as myocardial infarction,
stroke, and heart failure, which increase both mortality
and morbidity [1, 2]. Previous studies have revealed that
blood pressure in the pre-hypertensive range might be
associated with adverse cardiovascular outcomes [3].
High-normal blood pressure has been consistently asso-
ciated with an elevated risk of cardiovascular disease
[4, 5]. This association suggests that those with a prehy-
pertension (pre-HTN) blood pressure are prone to pro-
gress to HTN [6]. Therefore, it has become important to
manage health starting from the pre-HTN stage. The
Seventh Report of the Joint National Commission (JNC 7)
defined the range of HTN as systolic blood pressure (SBP)
greater than 140 mmHg or diastolic blood pressure (DBP)
greater than 90–99 mmHg [7]. It also defined the range
for pre-HTN as 120 to 139 mmHg for SBP or 80 to
89 mmHg for DBP, defining a new risk category as a
warning sign for developing HTN [7], with a low-end
threshold for pre-HTN that is lower than the previous
designation of high-normal blood pressure from the
JNC 6 guidelines of 120 to 130 mmHg for SBP and from
80 to 85 mmHg for DBP [8].
The number of people with uncontrolled HTN and
pre-HTN in the world has increased [9, 10] as the popu-
lation has increased and aged [11]. The prevalence of
uncontrolled HTN in Koreans is 22.9 % (26.9 % in men
and 20.5 % in women), and the prevalence of pre-HTN
was higher, at 31.6 % (41.9 % in men and 25.9 % in
women), in 2001 [12]. Although the main causes of
HTN and pre-HTN are unknown in most cases, genetic
and environmental factors, such as sex, age, ethnicity,
education, obesity, and several diseases, are suspected, in* Correspondence: bfree@kiom.re.kr2Mibyeong Research Center, Korea Institute of Oriental Medicine, 1672
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Western medicine, to be important causes of HTN and
pre-HTN [3, 13].
Sasang constitutional medicine (SCM) is a type of
Korean personalized traditional medicine that classifies
people into the following four types: Taeyangin type (TY
type), Soyangin type (SY type), Tae-eumin type (TE
type), and Soeumin type (SE type) [14]. Each Sasang
constitution (SC) type has a different susceptibility to
physio-pathology and several diseases [15]. Several stud-
ies have suggested that the SC types could be risk factors
for certain chronic diseases, including diabetes mellitus
(DM), abdominal obesity, metabolic syndrome, func-
tional dyspepsia, obstructive sleep apnea, and subclinical
hypothyroidism [16–22]. The WONCA International
Classification Committee defined chronic disease as long
in duration, often with a long latency period and pro-
tracted clinical course; having a multi-factorial etiology;
lacking a definite cure; and as gradually changing over
time with an asynchronous evolution and heterogeneity
in the population susceptibility [23]. The World Health
Organization reported that obesity, diabetes mellitus,
cardiovascular disease, HTN, stroke, and some cancer
types that are related to dietary and lifestyle patterns are
included in non-communicable diseases [24, 25].
From a preventive standpoint, the SC type is also con-
sidered to be crucial to the pre-disease and disease
stages [14]. Therefore, it is also important to determine
whether the SC type is a clinically important risk factor
for the pre-disease stage. Though trends in Western
medicine have recently focused on preventing disease,
SCM in Korean medicine has emphasized preventing
and predicting disease for a much longer period of time
[14]. However, few studies have found associations be-
tween the pre-disease states and SC types, except for a
study on abnormal glucose tolerance [17]. Recently, Lee’s
study suggested that the SC types could be risk factors
for HTN [26]. However, their study did not reveal SC to
be a risk factor for pre-HTN. The aim of the present
study was to present evidence for whether the SC types
could be independent risk factors for pre-HTN.
Methods
Subjects
This study was conducted from November 2006 to July
2013 in South Korean medical hospitals. Participants
older than 20 years old were recruited among the people
who visited the hospital for medical examinations.
Participants who could not understand or follow the
researchers’ instructions due to severe physical and men-
tal conditions, such as terminal cancer, were excluded.
Pregnant women were also excluded. A total of 3,683
subjects (1312 men and 2371 women) enrolled in this
study, but 25 were excluded because of missing data (21
for blood pressure data and 4 for body mass index data).
Because the TY type is fairly rare in Korea, 76 TY types
were excluded from this study. Additionally, because this
study focused on pre-HTN, 776 patients with HTN (365
men and 411 women), according to the guidelines of the
JNC 7 of ≥ 90 mmHg for DBP or ≥ 140 mmHg for SBP
(405 subjects), or who were taking medicine to treat
high blood pressure (409 subjects) were also excluded
from this study; one hundred twenty-eight subjects were
included in both of these categories. A total of 2,806
subjects (914 men and 1892 women) met the inclusion
criteria. A detailed flowchart of this study design is
shown in Fig. 1. The Korea Institute of Oriental Medi-
cine Institutional Review Board approved of this study
(KIOM IRB; number I-0910/02-001), and written in-
formed consent was obtained from each subject. A flow
chart of the subject enrollment is shown in Fig. 1.
Data collection
Blood pressure was measured from the subjects’ left
upper arms. To obtain stable blood pressure readings,
the subjects were asked to rest before the measurements.
The subjects’ height and weight were measured and
rounded to the nearest hundredth, and the body mass
index (BMI) was indirectly calculated from the height
and weight. Other information, including the sex and
age, and blood samples were collected to control for the
confounding influences of important risk factors for pre-
HTN. In particular, blood samples were collected after
more than 12 h of fasting, and the fasting blood glucose
(FBG), total cholesterol (TC), triglyceride (TGs), and
HDL and LDL cholesterol were tested at one authorized
institution (Seoul Medical Science Institute, SCL).
The instructors at each hospital met and were edu-
cated about the standardization of the data at least once
per year, and KIOM continued to monitor the process of
data collection several times per year. All of the instruc-
tors followed a standard operating procedure (SOP) that
was developed for the “Korea Constitution Multicenter
Study” [27].
Diagnosis of the Sasang constitution
For a more accurate diagnosis of the Sasang constitution
types, we confirmed three conditions according to a pre-
vious study [28]. First, the qualifications of the experts
were strictly limited. Those experts, who had more than
5 years of clinical experience in SCM practice, partici-
pated in this study at South Korean national hospitals.
They classified the subjects’ SC types based on their
temperament, body shape, appearance, voice and physio-
pathological symptoms. Generally, the inter- and intra-
observer validities among the experts were more than
60 % [29]. Second, the medical charts of the participants
were reviewed to determine whether they had taken
herbal medicine for more than one month. An additional
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method of confirming the participants’ SC types was
performed by assessing the participants’ health for SC-
specific pharmaceuticals because unsuitable herbal pre-
scriptions can cause adverse effects. Therefore, only those
subjects who showed good improvement with SC-specific
pharmaceuticals were candidate subjects. Last but not
least, qualified SCM experts re-diagnosed the participants’
SC types.
Diagnosis of pre-HTN
Pre-HTN was diagnosed according to the JNC 7 as
120–139 mmHg for SBP or 80–89 mmHg for DBP [7].
We classified the subjects into two groups and evaluated
them according to European guidelines as follows: low pre-
HTN (SBP 120–129 mmHg and/or DBP 80–84 mmHg)
and high pre-HTN (SBP 130–139 mmHg and/or DBP
85–89 mmHg) [30].
Statistical analyses
All of the data were analyzed separately according to
sex. One-way ANOVA with Scheffé’s post-hoc analysis
was conducted to compare the continuous variables.
The chi-square test was used to compare the prevalence
of pre-HTN according to the SC type. Multinorminal lo-
gistic regression was used to generate the odds ratios
(ORs) and 95 % confidence intervals (CIs) for normal,
low and high pre-HTN groups and binary logistic
regression was used for normal and pre-HTN groups.
To calculate the ORs, the risk of low pre-HTN (from
120 to129 mmHg for SBP or 80 to 84 mmHg for DBP),
high pre-HTN (from 130 to139 mmHg for SBP or 85
to 89 mmHg for DBP) and pre-HTN (from 120 to
139 mmHg for SBP or 80 to 89 mmHg for DBP) accord-
ing to the SC types were set and compared with the nor-
mal (below 120 mmHg for SBP and 80 mmHg for DBP)
group. Covariant variables, such as age, BMI, fasting
blood glucose, total cholesterol, triglycerides, and LDL
and HDL cholesterol, were adjusted to evaluate whether
the SC types could be risk factors for pre-HTN. The
statistical level of significance was set at a p value < 0.05




The numbers of participants in the SE, SY and TE types
were 229, 303 and 382 men, respectively, and 556, 660
and 676 women. The general characteristics, including
age and BMI, were significantly different among the SC
types. In detail, the SBP and DBP differed according to
the SC types, and blood pressure was highest for the TE
type. Other general characteristics, such as the BMI,
FBG, TC, TGs, and LDL, but not height or HDL level,
which are known potential risk factors for HTN, were
also highest for the TE type. The details are described
in Table 1.
Prevalence of pre-HTN status by Sasang constitution
The prevalence rates of low pre-HTN among the SE, SY
and TE types were 49.8 %, 42.9 % and 52.6 % in men, re-
spectively, and 32.2 %, 33.8 % and 38.5 % in women. The
prevalence rates of high pre-HTN among the SE, SY
and TE types were 9.6 %, 17.2 % and 22.3 % in men
(p < 0.001), respectively, and 9.5 % 10.6 % and 19.8 % in
women (p < 0.001). In total, the pre-HTN prevalence
rates of SE, SY and TE was 59.4 %, 60.1 % and 74.9 % in
men (p < 0.001), respectively, and 41.7 %, 44.4 % and
58.3 % (p < 0.001) in women. There was a significant dif-
ference in the pre-HTN prevalence between the normal
and pre-HTN groups (both the low and high pre-HTN
Fig. 1 Flow chart of the subject enrollment. SOP: standard operating procedure, BMI: body mass index, SC: Sasang constitution, SCM: Sasang
constitutional medicine, TY: Taeyangin, SE: Soeumin, SY: Soyangin, TE: Tae-eumin, M: men, and W: women
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groups) in both men and women. The details are shown
in Fig. 2.
Adjusted odds ratios for pre-HTN according to the
SC types
Because the comparatively higher SBP and DBP might
be influenced by age, BMI, and blood test results, it is
necessary to demonstrate the pure risk value of the SC
type alone. Table 2 presents the ORs for low pre-HTN,
high pre-HTN and pre-HTN according to the SC type.
The ORs of TE type for low pre-HTN was significantly
higher compared with the SE type in both crude (OR 1.71,
95 % CI 1.18–2.46 in men, OR 1.67, 95 % CI 1.3–2.14 in
women) and model 1 (OR 1.67, 95 % CI 1.16–2.42 in men,
OR 1.51, 95 % CI 1.17–1.94 in women). However, it showed
no significance in model 2 and model 3 after adjusting for
BMI variables. The ORs of TE type for high pre-HTN was
significantly higher compared with the SE type in crude
(OR 3.74, 95 % CI 2.16–6.48 in men, OR 2.9, 95 % CI 2.04–
4.15 in women), model 1 (OR 3.38, 95 % CI 1.94–5.88 in
men, OR 2.42, 95 % CI 1.67–3.5 in women) and model 2
(OR 2.43, 95 % CI 1.3–4.55 in men, OR 1.53, 95 %
CI 1.–2.32 in women). However, the ORs of TE type for
high pre-HTN was significantly higher compared with
the SE type alone in men (OR 2.57, 95 % CI 1.36–4.84),
after adjusting for all confounding variables in model 3.
Table 1 General characteristics of men and women according to Sasang constitution
Variables Men Women
SE type SY type TE type p value SE type SY type TE type p value
N (%) 229 (25.1) 303 (33.2) 382 (41.8) 556 (29.4) 660 (34.9) 676 (35.7)
Age 45.3 ± 14 50.4 ± 14.3 50.3 ± 14.8 <0.001 a, b 45.4 ± 14.5 46.6 ± 13.5 50 ± 15.1 <0.001 b, c
Height 169.9 ± 5.9 169.2 ± 5.9 170.2 ± 6.4 0.08 158.5 ± 5.7 157.3 ± 5.8 158 ± 5.9 0.001 a
Weight 62.7 ± 7.9 66.5 ± 8.6 74.5 ± 10.7 <0.001 a, b, c 52.4 ± 6.1 55.3 ± 6.8 62.3 ± 8.3 <0.001 a, b, c
BMI 21.7 ± 2.3 23.2 ± 2.5 25.7 ± 2.9 <0.001 a, b, c 20.9 ± 2.4 22.4 ± 2.7 25 ± 3.1 <0.001 a, b, c
SBP 114.1 ± 11.2 116.3 ± 9.5 119.2 ± 8.8 <0.001 a, b, c 111.7 ± 11.3 112.4 ± 11.1 115.3 ± 11.1 <0.001 b, c
DBP 72.7 ± 9.2 74.1 ± 7.5 75.8 ± 7 <0.001 b, c 71.4 ± 8.1 71.8 ± 8 73.8 ± 8 <0.001 b, c
FBG 96 ± 27.1 102 ± 28.1 101.9 ± 27.4 0.021 a, b 91.7 ± 14.7 94.9 ± 25.8 98.2 ± 26.4 <0.001 b, c
TC 178.5 ± 33.7 184.8 ± 35 184.4 ± 34 0.069 180.2 ± 32.7 187.6 ± 36.2 188.1 ± 34.9 <0.001 a, b
TG 116.8 ± 63.5 152.5 ± 104.2 160.1 ± 95.5 <0.001 a, b 93.4 ± 53.4 105.1 ± 60.6 123.4 ± 73.7 <0.001 a, b, c
HDL 46 ± 11.2 43.8 ± 11 40.7 ± 10 <0.001 b, c 53.3 ± 12.7 50.8 ± 12.6 47.9 ± 11.7 <0.001 a, b, c
LDL 103.4 ± 28.9 107.4 ± 30 108.1 ± 28.9 0.139 100.4 ± 28.7 108.4 ± 32.5 109.9 ± 30.5 <0.001 a, b
Data shown are the means ± SDs or numbers
aSoeumin and Soyangin differ significantly; bSoeumin and Tae-eumin differ significantly; and cSoyangin and Tae-eumin differ significantly
SE: Soeumin, SY: Soyangin, TE: Tae-eumin, BMI: body mass index, SBP: systolic blood pressure, DBP: diastolic blood pressure, FBG: fasting blood glucose, TC: total
cholesterol, TG: triglyceride, HDL: HDL cholesterol, and LDL: LDL cholesterol
Fig. 2 Prevalence of pre-HTN status by Sasang constitution. ap value, chi-square for normal, low and high pre-HTN among SC types in each men
(A) and women (B); bp value, chi-square for normal and pre-HTN among SC types in each men (A) and women (B); SE, Soeumin; SY, Soyangin; TE,
Tae-eumin; HTN, Hypertension
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The ORs of TE type for pre-HTN was significantly
higher compared with the SE type in both the crude
(OR 2.04, 95 % CI 1.43–2.89 in men, OR 1.95, 95 % CI
1.55–2.45 in women) and model 1 (OR 1.95, 95 % CI
1.37–2.78 in men, OR 1.7, 95 % CI 1.34–2.16 in women)
but it was not significantly higher in model 2. The ORs
of TE type for pre-HTN was significantly higher com-
pared with the SE type alone in men (OR 1.57, 95 % CI
1.03–2.39) even after adjusting for age, BMI, FBG, TC,
TGs, HDL and LDL, but it was not significant in
women. The ORs of SY type for pre-HTN including low
and high HTN was not significant compared with the SE
type, except for high pre-HTN in crude in men.
Discussion
This study focused on the SC type as a risk factor for
pre-HTN, which is an important component of prevent-
ive medicine. This study suggested that the prevalence
of pre-HTN in the TE type was highest in both men and
women. However, as the comparatively higher SBP and
DBP of the TE type might be influenced by the age,
BMI, and several laboratory blood test results, the ORs
for pre-HTN were calculated by logistic regression ana-
lysis, considering the influences of those potential vari-
ables. The TE type was associated with an increased OR
of high pre-HTN in men compared with the SE type
(OR 2.57, 95 % CI 1.36–4.84), but the TE type was not
associated with an increased ORs in women after
adjusting for the age, BMI, FBG, TC, TGs, and HDL and
LDL cholesterol. This finding indicated that the TE
types, combined with sex, might be significant and inde-
pendent risk factors for pre-HTN as well as might work
as predictive factors for pre-HTN, especially high pre-
HTN.
In details, logistic regression analysis showed that the
ORs of the TE type were significantly different from
those of the SE type, in crude analysis, for both men and
women. Because BMI is a well-known risk factor for
pre-HTN [31], we tried to exclude both the BMI effect
and other covariant variables through logistic regression
analysis. The ORs of pre-HTN for the TE type was
changed from 1.95 (p < .001, model 1) significantly to
1.5 (model 2) insignificantly and from 1.7 (p < .001,
model 1) significantly to 1.07 (model 2) insignificantly in
men and women compared with the SE type, respect-
ively. However, the ORs of TE type in men for pre-HTN
became significant again as 1.57 (p < .05) in model
3. From this view point not only BMI but also other co-
variant factors including SC seemed to affect to pre-
HTN in men.
There was a different trend between men and women,
wherein only the TE type in men was associated with an
increased OR (1.57, 95 % CI 1.03–2.39) of pre-HTN
compared with the SE type in model 3. These differences
seemed to arise from sexual characteristics because the
prevalence of pre-HTN is higher in men than in women
Table 2 Adjusted odds ratios and 95 % CIs for pre-HTN according to Sasang constitution
Men Women
SE SY TE SE SY TE
Low pre-HTN
Crude Ref. 0.88 (0.61–1.27) 1.71 (1.18–2.46)* Ref. 1.1 (0.86–1.41) 1.67 (1.3–2.14)**
Model 1 Ref. 0.86 (0.59–1.24) 1.67 (1.16–2.42)* Ref. 1.06 (0.82–1.36) 1.51 (1.17–1.94)*
Model 2 Ref. 0.78 (0.53–1.14) 1.31 (0.85–2.01) Ref. 0.88 (0.68–1.15) 0.93 (0.69–1.26)
Model 3 Ref. 0.78 (0.53–1.15) 1.36 (0.88–2.12) Ref. 0.87 (0.66–1.13) 0.92 (0.68–1.25)
High pre-HTN
Crude Ref. 1.82 (1.03–3.2)* 3.74 (2.16–6.48)** Ref. 1.17 (0.79–1.72) 2.9 (2.04–4.15)**
Model 1 Ref. 1.62 (0.92–2.88) 3.38 (1.94–5.88)** Ref. 1.12 (0.75–1.67) 2.42 (1.67–3.5)**
Model 2 Ref. 1.43 (0.8–2.57) 2.43 (1.3–4.55)* Ref. 0.94 (0.62–1.41) 1.53 (1–2.32)*
Model 3 Ref. 1.4 (0.78–2.54) 2.57 (1.36–4.84)* Ref. 0.91 (0.6–1.38) 1.48 (0.97–2.28)
Pre-HTN
Crude Ref. 1.03 (0.72–1.46) 2.04 (1.43–2.89)** Ref. 1.11 (0.89–1.4) 1.95 (1.55–2.45)**
Model 1 Ref. 0.98 (0.69–1.4) 1.95 (1.37–2.78)** Ref. 1.07 (0.84–1.36) 1.7 (1.34–2.16)**
Model 2 Ref. 0.88 (0.61–1.27) 1.5 (0.99–2.26) Ref. 0.89 (0.7–1.14) 1.07 (0.81–1.41)
Model 3 Ref. 0.88 (0.61–1.28) 1.57 (1.03–2.39)* Ref. 0.88 (0.68–1.12) 1.05 (0.79–1.39)
*p < 0.05 **p < 0.001
Model 1 adjusted for age
Model 2 adjusted for age and BMI
Model 3 adjusted for age, BMI, FBG, total cholesterol, triglyceride, and LDL and HDL cholesterol
low pre-HTN: SBP, 120 to 129 mmHg and/or DBP, 80 to 84 mmHg, high pre-HTN: SBP, 130 to 139 mmHg and/or DBP, 85 to 89 mmHg
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[31–34]. Numerous studies have also shown that females
have lower blood pressure levels throughout much of
their lives compared with their age-matched counter-
parts. These studies have insisted that the relatively
lower blood pressure levels in women are from the im-
portant role of sex hormones and different lifestyle, in-
cluding smoking status [35–37].
The TE type in men had substantially increased ORs
for high pre-HTN in particular, [38, 39]. The new cat-
egory, so-called pre-HTN (120 to 139 mmHg systolic or
80 to 89 mmHg diastolic) was included in the JNC 7
guidelines because HTN is strongly related to CVD [7].
The recent 2013 European Society of Hypertension/
European Society of Cardiology (ESH/ESC) guidelines
for HTN proposed seven categories of BP levels, dividing
pre-HTN into two categories, high pre-HTN (defined as
a systolic BP of 130–139 mm Hg and/or diastolic BP of
85–89 mm Hg) and low pre-HTN (defined as a systolic
BP of 120–129 mm Hg and/or diastolic BP of 80–
84 mm Hg). High pre-HTN is associated with an in-
creased risk of developing HTN as well as cardiovascular
disease, including atrial fibrillation, but low pre-HTN
has not been shown to be associated with an increased
risk of cardiovascular disease. As a result, active manage-
ment of lifestyle changes is necessary at the high pre-
HTN stage. That’s why pre-HTN was divided into low
and high pre-HTN. The TE type was significantly associ-
ated with an increased OR (2.43) in model 2 and OR
(2.57) in model 3 for high pre-HTN, but it was not sig-
nificantly associated with the OR (1.31) in model 2 and
OR (1.36) in model 3 for low pre-HTN compared with
the SE type, in men.
This result may be less conclusive because here, pre-
HTN is simply the early stage of HTN, in contrast to an-
other study [26], which reported that the TE type could
be a risk factor for HTN. However, the present study,
focusing on preventive view point at the early normal
stage of elevated blood pressure, suggests that the TE
type might be a risk factor for the high pre-HTN cat-
egory in men, so requires more careful attention for high
pre-HTN
This study had several strengths. First off, local bias
and measurement error of data may less affect to the re-
sult, because the participants in this study were recruited
nationwide from South Korean medical centers, and the
acquisition of data in this study was clarified by follow-
ing SOPs [27]. Secondly, this study followed preventive
trends, which is the latest fashion in health promotion,
by focusing on pre-disease HTN stages. This finding
might provide second-hand evidence for SCM that cor-
responds to the original preventive intention.
This study also had some limitations. Because of
its cross-sectional design, we could not determine a
cause-and-effect relationship between the SC type and
pre-HTN; as a result, the level of evidence was relatively
low. Although we considered the influences of potential
variables, we did not control for all of the risk factors
that influence pre-HTN. Furthermore, the blood pres-
sure of the subjects was only measured once, which
might not be in agreement with the European guidelines,
where blood pressure is classified based on two or more
readings taken on two or more separate occasions, with
at least one week between the measurements. Accord-
ingly, people with pre-HTN might be affected by the
white coat, or patients with masked HTN were included
or excluded.
Further studies with longer-term follow-up designs are
needed to confirm SC as an important risk factor for
pre-HTN.
Conclusion
The study findings suggested that SC, particularly the
TE type in men, might be significantly and independ-
ently associated with pre-HTN especially high pre-HTN,
revealing that SC could be an important health factor in
pre-HTN.
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